Back to Investors

Schroders Capital

Evidence PackPROIndependent
Private EquityNEW YORK, NY Website
AUM
$87600.0T
Ownership
independent
Stakeability
21 / VERY LOW
Priority
Tier 4
Employees
49

Schroders Capital is a privately owned investment company specializing in private equity and real assets.

SEC RegisteredFund PerformanceBDC ExposureTeam DataILS DealsRegulatoryNews Coverage

Coverage

58%

Adaptive profile: standard

Signals present
7/12
SEC / ADVFund Performance(50)BDC Exposure(5)13F Holders(0)Team(30)ILS Deals(2)Regulatory(25)Legal(0)Lobbying(0)Hiring(0)News(2)GP Stakes Deals(0)

Data Freshness

Recent Changes

Stakeability Breakdown

21 / 100
Fund PerformanceAUM growth and fundraising track record
6
Team StabilityLeadership continuity and key person risk
6
Market PositionBrand strength and competitive positioning
21
Succession ReadinessNext-gen leadership and governance structure
10
Transaction FeasibilityLikelihood of a stake transaction
14
Unable to load signal breakdown.

IC Risk Memo

PRO

Investment committee-ready memo with risk analysis and recommendation

Click "Generate Memo" to create an IC-ready analysis

Includes risk factors, citations, and recommendation

CRD Number
145194
SEC File Number
801-69112
Registration Type
Registered
Filing Date
Jun 29, 2025
Employee Count
N/A
Discretionary AUM
$27.5B
Private Funds
65
PE Funds
65
VC Funds
N/A
RE Funds
N/A
Hedge Funds
N/A
Gross Assets (Private)
$12.7B
Source: SEC IAPD

Fund performance data requires Professional

Upgrade your plan to access this section.

Upgrade

BDC exposure data requires Professional

Upgrade your plan to access this section.

Upgrade

Team data requires Professional

Upgrade your plan to access this section.

Upgrade

Team intelligence requires Professional

Upgrade your plan to access this section.

Upgrade

Competition mapping requires Professional

Upgrade your plan to access this section.

Upgrade

Regulatory data requires Professional

Upgrade your plan to access this section.

Upgrade

No GP stakes deals recorded

This GP has not sold a minority stake, making it a potential target.